CUSIP: 62957M104
What is CUSIP 62957M104?
CUSIP 62957M104 identifies NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 62957M104:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2017 Q4 | 0 | $0 | -$710,000 | 0 | |
| 2017 Q3 | 86,710 | $710,000 | -$51,708,939 | $8.19 | 1 |
| 2017 Q2 | 5,791,852 | $52,824,000 | -$120,362,723 | $10.48 | 4 |
| 2017 Q1 | 15,205,809 | $182,434,000 | +$4,300,138 | $11.99 | 25 |
| 2016 Q4 | 14,939,633 | $88,999,000 | +$19,022,694 | $5.96 | 24 |
| 2016 Q3 | 11,671,368 | $82,509,000 | -$485,000 | $7.05 | 20 |
| 2016 Q2 | 11,730,301 | $87,997,000 | -$11,477,835 | $7.50 | 20 |
| 2016 Q1 | 13,002,414 | $116,488,000 | +$20,323 | $8.96 | 20 |
| 2015 Q4 | 9,813,433 | $194,778,000 | -$2,104,093 | $9.60 | 21 |
| 2015 Q3 | 9,537,482 | $90,607,000 | +$90,607,000 | $9.50 | 18 |